Biotechnology

Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Col...

Insilico agreed to apply its Pharma.AI platform, which addresses target validati...

Backed by $165M, Bionyra Pharma Launches to Advance Inf...

The company, which emerged from stealth this week, is using the funds to develop...

Intravesical CAR T-Cell Therapy Reduces Bladder Cancer ...

Researchers identified the protein MUC16 as a clinically relevant target for bla...

Genome Editing at the Turning Point—Bringing CRISPR to ...

This GEN Live show will bring together a panel of leading experts to break down ...

Circio’s circVec and Tcelltech’s nanoSMAR Technologies ...

Circio and Tcelltech will combine Circio's circVec circular RNA expression techn...

Nipah and Hendra Viruses: Antibody Cocktail Provides Co...

Researchers developed the first human antibody cocktail to completely protect ag...

Heat waves mess with your brain. Scientists are trying ...

It’s been hot in London this week. Really hot. A dangerous heat wave has hit Wes...

BIO 2026: ‘I am alive today because of biotech’

From sickle cell disease to multiple sclerosis and childhood leukemia, patients ...

BIO 2026: Biotech threatened by pressures on patent pro...

At a time when U.S. biotech leadership is being challenged, the patent system th...

AI Framework Surfaces New CAR T Target with Multi‑Cance...

A human‑in‑the‑loop AI framework rapidly nominates CAR T targets, leading to a G...

BIO 2026: 340B faces growing calls for transparency, pa...

“The 340B drug pricing program was created to help safety net providers serve vu...

BIO 2026: FDA Leadership Confront Workforce Losses, Chi...

The panel, which featured the acting directors of Center for Drug Evaluation and...

Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding ...

The deal would add Bio-Techne’s multiomics offerings, analytical technologies, a...

Antibiotics Trigger Protein Sharing Among Bacteria, Aid...

Using a genetic system in E. coli, researchers discovered how bacteria work as a...

InduPro Licenses Lonza’s Linker Payload Technologies an...

Lonza and InduPro signed the licensing agreement to develop differentiated thera...

BIO 2026: American biotech leadership protects patients...

U.S. biotech leadership is essential to ensure patients have access to the best ...